H. Yoshida, Shoichi Yamamoto, Takumi Matsushita, T. Shibuya, Kazuya Takahashi, K. Baba, Y. Komasa, T. Ohkubo, K. Kakudo, S. Morita
{"title":"门诊灼口综合征患者初步筛查血检资料的初步临床研究","authors":"H. Yoshida, Shoichi Yamamoto, Takumi Matsushita, T. Shibuya, Kazuya Takahashi, K. Baba, Y. Komasa, T. Ohkubo, K. Kakudo, S. Morita","doi":"10.4172/2247-2452.1000919","DOIUrl":null,"url":null,"abstract":"Study background: The objective of study is a survey to report the prevalence of burning mouth syndrome (BMS) and to evaluated the co-morbidities associated to BMS. Subjects and Methods: A total 393 patients (54 males and 339 females; mean age 67 years; age range 27-102) were selected for this study. We carried out initial screening blood tests to these patients. Furthermore, we examined if there were previous and/or present systemic diseases and regularly taken medication by medical interview. Results: Female patients over 50 years old accounted for 89.3% (351/393). Dry mouth (330/393: 84.0%) was the most concomitant symptom with BMS. The ratio of abnormal measurements of iron was 35.9% (141/393). Zinc was 12.2% (48/393). However, the higher outrange ratio of MCV was 39.9% (157/393) and the lower outrange ratio of MCV was 8.7% (34/393). The higher outrange ratio of MCH was 36.6% (144/393) and the lower outrange ratio of MCH was 6.4% (25/393). The highest ratio of systematic disease of hypertension was 34.6% (136/393). Conclusions: We suspected that pernicious anemia may be most important factor of the BMS. Many patients had a number of systemic diseases and were taking several kinds of medicine. BMS is very complex disease, so it needs that more detailed investigation of systematic disease and habitual drug-taking is also needed.","PeriodicalId":19556,"journal":{"name":"Oral health and dental management","volume":"34 1","pages":"270-273"},"PeriodicalIF":0.0000,"publicationDate":"2016-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preliminary Clinical Study of Initial Screening Blood Test Data onOutpatients with Burning Mouth Syndrome\",\"authors\":\"H. Yoshida, Shoichi Yamamoto, Takumi Matsushita, T. Shibuya, Kazuya Takahashi, K. Baba, Y. Komasa, T. Ohkubo, K. Kakudo, S. Morita\",\"doi\":\"10.4172/2247-2452.1000919\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Study background: The objective of study is a survey to report the prevalence of burning mouth syndrome (BMS) and to evaluated the co-morbidities associated to BMS. Subjects and Methods: A total 393 patients (54 males and 339 females; mean age 67 years; age range 27-102) were selected for this study. We carried out initial screening blood tests to these patients. Furthermore, we examined if there were previous and/or present systemic diseases and regularly taken medication by medical interview. Results: Female patients over 50 years old accounted for 89.3% (351/393). Dry mouth (330/393: 84.0%) was the most concomitant symptom with BMS. The ratio of abnormal measurements of iron was 35.9% (141/393). Zinc was 12.2% (48/393). However, the higher outrange ratio of MCV was 39.9% (157/393) and the lower outrange ratio of MCV was 8.7% (34/393). The higher outrange ratio of MCH was 36.6% (144/393) and the lower outrange ratio of MCH was 6.4% (25/393). The highest ratio of systematic disease of hypertension was 34.6% (136/393). Conclusions: We suspected that pernicious anemia may be most important factor of the BMS. Many patients had a number of systemic diseases and were taking several kinds of medicine. BMS is very complex disease, so it needs that more detailed investigation of systematic disease and habitual drug-taking is also needed.\",\"PeriodicalId\":19556,\"journal\":{\"name\":\"Oral health and dental management\",\"volume\":\"34 1\",\"pages\":\"270-273\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral health and dental management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2247-2452.1000919\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral health and dental management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2247-2452.1000919","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preliminary Clinical Study of Initial Screening Blood Test Data onOutpatients with Burning Mouth Syndrome
Study background: The objective of study is a survey to report the prevalence of burning mouth syndrome (BMS) and to evaluated the co-morbidities associated to BMS. Subjects and Methods: A total 393 patients (54 males and 339 females; mean age 67 years; age range 27-102) were selected for this study. We carried out initial screening blood tests to these patients. Furthermore, we examined if there were previous and/or present systemic diseases and regularly taken medication by medical interview. Results: Female patients over 50 years old accounted for 89.3% (351/393). Dry mouth (330/393: 84.0%) was the most concomitant symptom with BMS. The ratio of abnormal measurements of iron was 35.9% (141/393). Zinc was 12.2% (48/393). However, the higher outrange ratio of MCV was 39.9% (157/393) and the lower outrange ratio of MCV was 8.7% (34/393). The higher outrange ratio of MCH was 36.6% (144/393) and the lower outrange ratio of MCH was 6.4% (25/393). The highest ratio of systematic disease of hypertension was 34.6% (136/393). Conclusions: We suspected that pernicious anemia may be most important factor of the BMS. Many patients had a number of systemic diseases and were taking several kinds of medicine. BMS is very complex disease, so it needs that more detailed investigation of systematic disease and habitual drug-taking is also needed.